CATALOGO DEI PRODOTTI DELLA RICERCA

MAGLIOZZI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.551
NA - Nord America 3.010
AS - Asia 2.749
SA - Sud America 471
AF - Africa 64
OC - Oceania 12
Totale 9.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.918
RU - Federazione Russa 1.682
SG - Singapore 1.125
CN - Cina 827
GB - Regno Unito 522
BR - Brasile 377
IT - Italia 309
HK - Hong Kong 291
SE - Svezia 215
VN - Vietnam 199
FR - Francia 185
DE - Germania 179
IE - Irlanda 176
FI - Finlandia 92
CA - Canada 63
KR - Corea 57
TR - Turchia 52
ID - Indonesia 48
UA - Ucraina 40
AR - Argentina 37
AT - Austria 32
IN - India 28
NL - Olanda 26
JP - Giappone 23
PL - Polonia 22
BD - Bangladesh 21
MX - Messico 20
EC - Ecuador 18
BE - Belgio 15
CO - Colombia 12
ZA - Sudafrica 12
BJ - Benin 11
TG - Togo 11
UZ - Uzbekistan 11
AZ - Azerbaigian 10
ES - Italia 10
IQ - Iraq 10
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
EG - Egitto 6
LT - Lituania 6
NZ - Nuova Zelanda 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
HR - Croazia 5
MA - Marocco 5
PK - Pakistan 5
PT - Portogallo 5
PY - Paraguay 5
BY - Bielorussia 4
IL - Israele 4
LA - Repubblica Popolare Democratica del Laos 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JO - Giordania 3
KZ - Kazakistan 3
PE - Perù 3
QA - Qatar 3
BH - Bahrain 2
BO - Bolivia 2
GY - Guiana 2
HN - Honduras 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
MU - Mauritius 2
OM - Oman 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
BB - Barbados 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
Totale 9.855
Salva come PNG Salva come JPEG
Città #
Moscow 570
Singapore 479
Chandler 428
Southend 424
Dallas 368
Ashburn 366
Hong Kong 289
Jacksonville 185
Dublin 175
Beijing 146
Verona 114
Princeton 78
Lawrence 71
The Dalles 71
Los Angeles 67
Ann Arbor 65
Jinan 61
Columbus 59
Wilmington 58
Dong Ket 56
Nanjing 53
Munich 50
Woodbridge 47
Ho Chi Minh City 45
Redondo Beach 43
Tianjin 43
Istanbul 42
Redmond 42
Houston 41
São Paulo 41
New York 40
Jakarta 39
Hanoi 36
Lappeenranta 35
Buffalo 33
Helsinki 33
Shenyang 29
London 28
Changsha 27
Council Bluffs 25
Ningbo 24
Zhengzhou 24
Montreal 23
Montréal 23
Nuremberg 23
Sindelfingen 23
Taizhou 22
Haikou 21
Santa Clara 21
Hebei 19
Redwood City 19
Warsaw 19
Tokyo 18
Vienna 18
Hangzhou 17
Lancaster 17
Nanchang 17
Seattle 17
Seoul 17
Chennai 16
Guangzhou 16
Milan 16
Rome 15
Jiaxing 14
Rio de Janeiro 14
Brussels 13
Norwalk 13
Washington 13
Brooklyn 12
Chicago 12
Mcallen 12
Bologna 11
Cotonou 11
Lomé 11
Turku 11
Atlanta 10
Baku 10
Falls Church 10
Orem 10
Phoenix 10
Stockholm 10
Amsterdam 9
Frankfurt am Main 9
Tashkent 9
Belo Horizonte 8
Boston 8
Denver 8
Johannesburg 8
Manchester 8
Poplar 8
Porto Alegre 8
Brasília 7
Dhaka 7
Falkenstein 7
Guayaquil 7
Padova 7
Querétaro 7
San Francisco 7
Taiyuan 7
Auckland 6
Totale 5.699
Salva come PNG Salva come JPEG
Nome #
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 264
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 191
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 184
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 184
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 179
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 173
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies 165
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 164
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 163
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 153
Epilepsy in multiple sclerosis: The role of temporal lobe damage 153
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 149
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 147
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 146
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 144
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 141
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 140
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 138
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis 137
B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis 134
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 134
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 131
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats 130
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 129
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 129
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 128
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 126
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 125
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis 125
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 124
Can CSF biomarkers predict future MS disease activity and severity? 121
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 120
Exploring the origins of grey matter damage in multiple sclerosis. 119
Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon 116
Aging, cellular senescence, and progressive Multiple Sclerosis 114
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 113
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 113
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain 112
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 112
A gradient of neuronal loss and meningeal inflammation in multiple sclerosis 111
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells 109
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 107
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 105
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain 104
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis 103
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 99
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 99
Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis 96
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination 94
Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice 93
A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis 93
Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV 92
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology 91
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation 90
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination 89
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 88
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 88
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis 88
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 88
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 87
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis 87
Effects of the plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry and morphometric analysis 85
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis 84
The BAFF / APRIL system as therapeutic target in multiple sclerosis 84
Meningeal inflammation and cortical demyelination in acute multiple sclerosis 84
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 82
Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis 82
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein 82
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 82
Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look 81
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study 81
Lymphoid chemokines in chronic neuroinflammation 80
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis 79
Intracerebral regulation of immune responses 77
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis 76
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome 75
Impact of neuronal loss on relaxometry and magnetization transfer imaging estimations 74
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 68
Intrathecal inflammation in progressive multiple sclerosis 66
A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis 65
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis 65
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury 65
Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study 64
Editorial: B cells in inflammatory and neurodegenerative diseases of the central nervous system 63
Surface-in pathology in multiple sclerosis: a new view on pathogenesis? 61
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation 60
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 59
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis 58
snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses 54
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis 51
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 49
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 49
Differences in age-related retinal and cortical atrophy rates in multiple sclerosis 48
Comparing the pathology, clinical and demographic characteristics of younger and older-onset multiple sclerosis 43
Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II 37
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications 23
Totale 10.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.699
article - articoli 36.547
book - libri 0
conference - conferenze 1.152
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021248 0 0 0 0 0 64 15 4 14 12 64 75
2021/2022556 36 171 1 72 18 7 19 40 20 19 30 123
2022/20231.208 86 147 115 223 68 282 22 69 157 4 18 17
2023/2024612 17 50 48 62 74 87 46 50 2 60 84 32
2024/20252.139 75 141 69 345 94 104 88 137 338 156 170 422
2025/20263.931 451 323 392 943 1.563 259 0 0 0 0 0 0
Totale 10.007